CHORIOGONADOTROPIN ALFA

CHORIOGONADOTROPIN ALFA was reported 2614 times

CHORIOGONADOTROPIN ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AICHMOPHOBIA 1 0.5000
1 CHOLANGIOSARCOMA 3 0.3750
2 HUMAN CHORIONIC GONADOTROPIN NEGATIVE 6 0.2857
3 OVARIAN HYPERSTIMULATION SYNDROME 640 0.2743
4 HYPOTHALAMIC ENLARGEMENT 1 0.2500
5 LUTEINISING UNRUPTURED FOLLICLE SYNDROME 1 0.2000
6 POOR RESPONSE TO OVULATION INDUCTION 2 0.1818
7 SEX CHROMOSOME ABNORMALITY 3 0.1429
8 PROTEIN S ABNORMAL 2 0.1429
9 ARTIFICIAL INSEMINATION 1 0.1429
10 CRI DU CHAT SYNDROME 1 0.1250
11 KAYSER-FLEISCHER RING 1 0.1250
12 DECREASED EMBRYO VIABILITY 3 0.1250
13 TRISOMY 22 2 0.1176
14 OVARIAN HAEMORRHAGE 25 0.1055
15 FAILED IN VITRO FERTILISATION 5 0.0820
16 HYPOPITUITARISM FOETAL 1 0.0769
17 MULTIPLE PREGNANCY 12 0.0670
18 VAGINAL CUFF DEHISCENCE 2 0.0667
19 HETEROTOPIC PREGNANCY 4 0.0635
20 OVARIAN ENLARGEMENT 23 0.0601
21 DIMINISHED OVARIAN RESERVE 1 0.0526
22 ENCEPHALITIS POST VARICELLA 1 0.0526
23 DRUG DISPENSING ISSUE 1 0.0526
24 PREMATURE OVULATION 4 0.0513
25 TUBEROUS SCLEROSIS 2 0.0465
26 CORRECTED TRANSPOSITION OF GREAT VESSELS 1 0.0455
27 HUMAN CHORIONIC GONADOTROPIN DECREASED 5 0.0450
28 VANISHING TWIN SYNDROME 4 0.0449
29 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 3 0.0435
30 ENDOMETRIAL HYPOPLASIA 1 0.0417
31 PREGNANCY TEST NEGATIVE 4 0.0381
32 ADNEXAL TORSION 12 0.0379
33 RHABDOMYOMA 2 0.0377
34 BIOCHEMICAL PREGNANCY 4 0.0370
35 PROGESTERONE INCREASED 4 0.0360
36 HUMAN CHORIONIC GONADOTROPIN POSITIVE 2 0.0351
37 HUMAN CHORIONIC GONADOTROPIN ABNORMAL 2 0.0345
38 CAPUT SUCCEDANEUM 1 0.0345
39 OVARIAN RUPTURE 4 0.0342
40 ANOVULATORY CYCLE 7 0.0338
41 OVARIAN ABSCESS 5 0.0321
42 NONINFECTIVE OOPHORITIS 2 0.0299
43 ADRENAL INSUFFICIENCY NEONATAL 1 0.0294
44 TUBO-OVARIAN ABSCESS 7 0.0287
45 BLOOD OESTROGEN INCREASED 16 0.0272
46 PELVIC FLUID COLLECTION 19 0.0270
47 OVARIAN TORSION 2 0.0241
48 HETEROTAXIA 4 0.0240
49 HAEMOCONCENTRATION 4 0.0231
50 BASILAR ARTERY THROMBOSIS 4 0.0222
51 HYDROSALPINX 2 0.0217
52 OOPHORITIS 3 0.0211
53 CEPHALO-PELVIC DISPROPORTION 4 0.0200
54 KIDNEY ANGIOMYOLIPOMA 1 0.0200
55 VERTEBRAL ARTERY DISSECTION 4 0.0196
56 TWIN PREGNANCY 16 0.0190
57 PRODUCT RECONSTITUTION QUALITY ISSUE 17 0.0190
58 ADNEXA UTERI CYST 3 0.0185
59 AUTOSOMAL CHROMOSOME ANOMALY 1 0.0185
60 BENIGN HYDATIDIFORM MOLE 6 0.0181
61 HYPOOSMOLAR STATE 2 0.0163
62 MELANODERMA 3 0.0156
63 LEUKOPENIA NEONATAL 1 0.0152
64 BORDERLINE OVARIAN TUMOUR 1 0.0149
65 DRUG EXPOSURE BEFORE PREGNANCY 15 0.0148
66 BLOOD HUMAN CHORIONIC GONADOTROPIN INCREASED 3 0.0141
67 BLADDER TAMPONADE 4 0.0132
68 SECONDARY HYPOTHYROIDISM 2 0.0131
69 PELVIC HAEMATOMA 5 0.0113
70 MYCOBACTERIUM FORTUITUM INFECTION 2 0.0108
71 ECTOPIC PREGNANCY 33 0.0107
72 BLOOD VISCOSITY ABNORMAL 1 0.0105
73 CLINICALLY ISOLATED SYNDROME 1 0.0105
74 MATERNAL EXPOSURE BEFORE PREGNANCY 71 0.0104
75 ABORTION SPONTANEOUS INCOMPLETE 1 0.0103
76 ABORTION THREATENED 5 0.0100
77 PRODUCT ADMINISTRATION ISSUE 2 0.0096
78 OVULATION PAIN 2 0.0095
79 CEPHALHAEMATOMA 1 0.0090
80 ABDOMINAL REBOUND TENDERNESS 1 0.0089
81 INSULIN-LIKE GROWTH FACTOR ABNORMAL 1 0.0088
82 CYST RUPTURE 6 0.0088
83 BREAST DISORDER MALE 1 0.0086
84 OVARIAN CYST RUPTURED 11 0.0086
85 FONTANELLE BULGING 1 0.0085
86 CEREBROSPINAL FLUID RETENTION 1 0.0085
87 DYSPLASTIC NAEVUS 3 0.0083
88 HEPATO-LENTICULAR DEGENERATION 1 0.0079
89 OVARIAN FAILURE 4 0.0075
90 OVARIAN DISORDER 7 0.0074
91 BONE FISSURE 3 0.0072
92 COR PULMONALE ACUTE 2 0.0071
93 DELAYED DELIVERY 1 0.0070
94 HAEMORRHAGIC ASCITES 2 0.0070
95 HAEMORRHAGIC OVARIAN CYST 4 0.0070
96 ENDOMETRIAL ATROPHY 1 0.0069
97 ACUTE ABDOMEN 10 0.0068
98 OESTRADIOL INCREASED 2 0.0066
99 LIPOSUCTION 1 0.0065
100 RUPTURED ECTOPIC PREGNANCY 5 0.0065
101 POLYCYSTIC OVARIES 10 0.0064
102 PROGESTERONE DECREASED 2 0.0064
103 FOETAL GROWTH ABNORMALITY 1 0.0064
104 AMNIOCENTESIS ABNORMAL 1 0.0064
105 BLADDER INJURY 2 0.0063
106 OESTRADIOL DECREASED 2 0.0062
107 ANAPLASTIC ASTROCYTOMA 1 0.0061
108 TESTICULAR DISORDER 6 0.0060
109 CEREBELLAR HYPOPLASIA 1 0.0060
110 SUPRAPUBIC PAIN 3 0.0059
111 FOETAL CHROMOSOME ABNORMALITY 1 0.0059
112 ANAEMIA OF PREGNANCY 1 0.0058
113 TESTICULAR ATROPHY 5 0.0057
114 ANDROGEN DEFICIENCY 2 0.0057
115 MENTAL RETARDATION 2 0.0057
116 PUNCTURE SITE HAEMORRHAGE 4 0.0056
117 BLOOD LUTEINISING HORMONE DECREASED 1 0.0056
118 POOR QUALITY PRODUCT ADMINISTERED 58 0.0055
119 ADNEXA UTERI PAIN 7 0.0055
120 HYDROMETRA 1 0.0054
121 LID SULCUS DEEPENED 2 0.0054
122 HEPATIC VASCULAR THROMBOSIS 1 0.0052
123 INJECTION SITE ECZEMA 1 0.0052
124 CONGENITAL PULMONARY HYPERTENSION 1 0.0052
125 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 2 0.0051
126 PREGNANCY TEST POSITIVE 2 0.0051
127 HAEMOPERITONEUM 4 0.0050
128 MANUFACTURING MATERIALS ISSUE 2 0.0050
129 ABORTION MISSED 6 0.0047
130 CHORIORETINITIS 3 0.0047
131 JUGULAR VEIN THROMBOSIS 8 0.0045
132 CONGENITAL PULMONARY VALVE ATRESIA 1 0.0045
133 FAT REDISTRIBUTION 1 0.0043
134 PREGNANCY TEST FALSE POSITIVE 2 0.0043
135 INJECTION SITE GRANULOMA 1 0.0042
136 INTRA-ABDOMINAL HAEMORRHAGE 10 0.0042
137 FOREIGN BODY REACTION 1 0.0041
138 ENCEPHALOCELE 1 0.0040
139 CEREBRAL ARTERY THROMBOSIS 2 0.0039
140 EPILEPTIC AURA 1 0.0039
141 CONGENITAL HYPOTHYROIDISM 1 0.0039
142 INTRA-UTERINE DEATH 6 0.0037
143 CLINODACTYLY 1 0.0036
144 GENITOURINARY TRACT INFECTION 1 0.0035
145 ADNEXA UTERI MASS 1 0.0035
146 FALLOPIAN TUBE DISORDER 1 0.0034
147 EAR TUBE INSERTION 1 0.0034
148 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
149 CONGENITAL CHOROID PLEXUS CYST 1 0.0033
150 HYPNAGOGIC HALLUCINATION 1 0.0033
151 PELVIC DISCOMFORT 3 0.0032
152 FOETAL CARDIAC DISORDER 1 0.0032
153 ASCITES 92 0.0031
154 MENSTRUATION NORMAL 1 0.0030
155 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
156 LUNG PERFORATION 1 0.0030
157 WAIST CIRCUMFERENCE INCREASED 3 0.0029
158 JOINT ABSCESS 1 0.0029
159 OVERLAP SYNDROME 2 0.0029
160 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
161 KIDNEY MALFORMATION 1 0.0028
162 INTRA-ABDOMINAL FLUID COLLECTION 5 0.0028
163 AMNIOTIC CAVITY INFECTION 2 0.0028
164 CEREBRAL VENOUS THROMBOSIS 5 0.0028
165 OVARIAN MASS 2 0.0027
166 LOCAL REACTION 2 0.0027
167 INFERTILITY 4 0.0027
168 COMPLICATION OF PREGNANCY 2 0.0026
169 AZOOSPERMIA 1 0.0026
170 HYPEREMESIS GRAVIDARUM 1 0.0026
171 BLIGHTED OVUM 1 0.0025
172 ENDOMETRIAL HYPERTROPHY 1 0.0025
173 SUPERIOR SAGITTAL SINUS THROMBOSIS 2 0.0025
174 PRODUCT CONTAINER ISSUE 21 0.0024
175 LOW SET EARS 1 0.0024
176 HYDROTHORAX 2 0.0024
177 MELANOMA RECURRENT 1 0.0024
178 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
179 PRODUCT CONTAMINATION PHYSICAL 6 0.0024
180 PATERNAL EXPOSURE DURING PREGNANCY 2 0.0023
181 PRODUCT LEAKAGE 13 0.0023
182 INFERTILITY MALE 1 0.0022
183 BONE INFARCTION 1 0.0022
184 FOETAL HEART RATE ABNORMAL 2 0.0022
185 ATRIOVENTRICULAR SEPTAL DEFECT 1 0.0021
186 THERAPEUTIC RESPONSE INCREASED 2 0.0021
187 MASTOCYTOSIS 1 0.0021
188 PLACENTAL DISORDER 2 0.0021
189 OVARIAN CYST 21 0.0021
190 HYPERCOAGULATION 4 0.0021
191 PREMATURE RUPTURE OF MEMBRANES 5 0.0021
192 TENSION 12 0.0020
193 CERVICAL INCOMPETENCE 1 0.0020
194 HYPERLIPASAEMIA 1 0.0019
195 ANAL ATRESIA 1 0.0019
196 ABORTION SPONTANEOUS 75 0.0019
197 BLOOD GASES ABNORMAL 1 0.0019
198 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 2 0.0018
199 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
200 HAEMORRHAGIC INFARCTION 1 0.0018
201 BLOOD TESTOSTERONE ABNORMAL 2 0.0018
202 EPSTEIN-BARR VIRAEMIA 2 0.0018
203 CYTOGENETIC ABNORMALITY 2 0.0018
204 ANENCEPHALY 1 0.0018
205 SUBCLAVIAN VEIN THROMBOSIS 2 0.0018
206 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
207 PRODUCT PREPARATION ISSUE 11 0.0017
208 LOW BIRTH WEIGHT BABY 13 0.0016
209 HYDROPS FOETALIS 1 0.0016
210 XEROSIS 2 0.0016
211 ADENOCARCINOMA OF COLON 3 0.0016
212 VAGINAL ODOUR 2 0.0016
213 ABDOMINAL PAIN LOWER 40 0.0016
214 HYPOPROTEINAEMIA 3 0.0016
215 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
216 DRUG LEVEL DECREASED 16 0.0016
217 EXTREMITY CONTRACTURE 1 0.0016
218 PRODUCT AVAILABILITY ISSUE 35 0.0015
219 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
220 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 50 0.0015
221 INFECTIOUS PERITONITIS 1 0.0015
222 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
223 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
224 PERITONEAL HAEMORRHAGE 2 0.0014
225 LEIOMYOMA 1 0.0014
226 CHRONIC FATIGUE SYNDROME 2 0.0014
227 CONGENITAL HYDRONEPHROSIS 1 0.0014
228 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
229 PELVIC VENOUS THROMBOSIS 2 0.0014
230 HAEMORRHAGE IN PREGNANCY 2 0.0014
231 LARYNGEAL DISORDER 1 0.0014
232 ABORTION INDUCED 13 0.0014
233 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
234 LIQUID PRODUCT PHYSICAL ISSUE 10 0.0014
235 THYROIDITIS 4 0.0013
236 BLOOD LOSS ANAEMIA 3 0.0013
237 PRODUCT STORAGE ISSUE 5 0.0013
238 INFERTILITY FEMALE 2 0.0013
239 INJECTION SITE HYPERSENSITIVITY 4 0.0013
240 METAPNEUMOVIRUS INFECTION 1 0.0013
241 BLOOD FIBRINOGEN INCREASED 1 0.0013
242 AORTIC DISORDER 1 0.0013
243 TESTICULAR PAIN 4 0.0013
244 NO ADVERSE EVENT 227 0.0013
245 HEPATITIS VIRAL 1 0.0012
246 DIABETES INSIPIDUS 3 0.0012
247 BREAST OPERATION 1 0.0012
248 PELVIC PAIN 22 0.0012
249 SMALL FOR DATES BABY 6 0.0012
250 COVID-19 IMMUNISATION 1 0.0012
251 CULTURE POSITIVE 1 0.0012
252 AMAUROSIS 1 0.0012
253 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
254 CHOROIDAL NEOVASCULARISATION 1 0.0012
255 CORONARY ARTERY DISSECTION 1 0.0012
256 ABSCESS DRAINAGE 1 0.0012
257 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
258 AXIAL SPONDYLOARTHRITIS 1 0.0011
259 LARGE FOR DATES BABY 1 0.0011
260 PRODUCT DOSE OMISSION 74 0.0011
261 BREAST SWELLING 3 0.0011
262 UTERINE POLYP 2 0.0011
263 IMPLANT SITE PRURITUS 1 0.0011
264 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
265 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
266 ABDOMINAL DISTENSION 113 0.0011
267 MENINGIOMA BENIGN 1 0.0011
268 PREMATURE LABOUR 6 0.0011
269 LIPOATROPHY 1 0.0011
270 RETINAL VEIN OCCLUSION 3 0.0010
271 CAESAREAN SECTION 12 0.0010
272 ABORTION 3 0.0010
273 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
274 HORMONE LEVEL ABNORMAL 5 0.0010
275 BLOOD TESTOSTERONE DECREASED 7 0.0010
276 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
277 HAEMOPHILUS INFECTION 1 0.0010
278 DUST ALLERGY 1 0.0010
279 VENOUS THROMBOSIS 4 0.0010
280 HEMIANOPIA 1 0.0010
281 MESENTERIC VEIN THROMBOSIS 1 0.0010
282 LIBIDO INCREASED 2 0.0010
283 NIPPLE PAIN 2 0.0010
284 PRODUCT SUPPLY ISSUE 7 0.0010
285 VENOUS THROMBOSIS LIMB 2 0.0010
286 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
287 OLIGURIA 6 0.0010
288 FEEDING DISORDER NEONATAL 1 0.0010
289 LIVE BIRTH 8 0.0010
290 HYDROCELE 1 0.0009
291 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
292 CEREBRAL ARTERY OCCLUSION 1 0.0009
293 FOETAL MALFORMATION 1 0.0009
294 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
295 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
296 OLIGOHYDRAMNIOS 3 0.0009
297 CLEFT LIP AND PALATE 1 0.0009
298 DRUG EFFECT VARIABLE 1 0.0009
299 HAEMATOCRIT INCREASED 2 0.0009
300 PLEURAL EFFUSION 53 0.0009
301 DRUG EXPOSURE DURING PREGNANCY 29 0.0009
302 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
303 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 2 0.0008
304 PRODUCT PACKAGING ISSUE 8 0.0008
305 ENDOMETRIOSIS 4 0.0008
306 EMBOLISM ARTERIAL 1 0.0008
307 STILLBIRTH 4 0.0008
308 FOETAL GROWTH RESTRICTION 5 0.0008
309 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
310 HYPERAESTHESIA TEETH 1 0.0008
311 RETINAL ARTERY OCCLUSION 2 0.0008
312 GASTRIC ULCER PERFORATION 1 0.0008
313 DERMATOMYOSITIS 2 0.0008
314 WEIGHT LOSS POOR 4 0.0008
315 PRODUCT COLOUR ISSUE 4 0.0008
316 GESTATIONAL HYPERTENSION 1 0.0008
317 FOETAL DEATH 4 0.0008
318 ABDOMINAL OPERATION 1 0.0008
319 EXPOSURE VIA FATHER 1 0.0008
320 EXPOSURE VIA BREAST MILK 3 0.0008
321 PREGNANCY 15 0.0007
322 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
323 LARGE INTESTINAL ULCER 2 0.0007
324 NORMAL NEWBORN 4 0.0007
325 HYDROCEPHALUS 4 0.0007
326 EFFUSION 1 0.0007
327 DEMYELINATION 3 0.0007
328 DEATH NEONATAL 1 0.0007
329 LUNG CONSOLIDATION 2 0.0007
330 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
331 PRODUCT QUALITY ISSUE 96 0.0007
332 UTERINE HAEMORRHAGE 3 0.0007
333 INTENSIVE CARE 1 0.0007
334 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
335 DYSPNOEA AT REST 2 0.0007
336 PULMONARY PAIN 2 0.0007
337 MELANOCYTIC NAEVUS 3 0.0007
338 UTERINE LEIOMYOMA 5 0.0007
339 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
340 AXILLARY PAIN 1 0.0007
341 ILEUS PARALYTIC 3 0.0007
342 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
343 PRODUCT PHYSICAL ISSUE 13 0.0006
344 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
345 HYPERTHYROIDISM 9 0.0006
346 LEUKOCYTOCLASTIC VASCULITIS 1 0.0006
347 PRODUCT FORMULATION ISSUE 4 0.0006
348 GASTRIC DILATATION 1 0.0006
349 BK VIRUS INFECTION 2 0.0006
350 VULVOVAGINAL PRURITUS 3 0.0006
351 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
352 SUDDEN CARDIAC DEATH 2 0.0006
353 NEEDLE ISSUE 17 0.0006
354 CEREBRAL ISCHAEMIA 3 0.0006
355 VIITH NERVE PARALYSIS 2 0.0006
356 HYPOPITUITARISM 1 0.0006
357 LACK OF INJECTION SITE ROTATION 1 0.0006
358 FOOD INTERACTION 1 0.0006
359 PREMATURE BABY 17 0.0006
360 FIBRIN D DIMER INCREASED 2 0.0006
361 PRODUCT CONTAMINATION 2 0.0006
362 PRODUCT PRESCRIBING ISSUE 12 0.0006
363 ESSENTIAL HYPERTENSION 1 0.0005
364 DYSENTERY 1 0.0005
365 RETINOPATHY 2 0.0005
366 INCORRECT PRODUCT STORAGE 7 0.0005
367 PROTEIN TOTAL DECREASED 2 0.0005
368 JAUNDICE NEONATAL 1 0.0005
369 PROSTATOMEGALY 2 0.0005
370 AFFECTIVE DISORDER 4 0.0005
371 DIPLEGIA 1 0.0005
372 EMPYEMA 1 0.0005
373 ANORECTAL DISORDER 1 0.0005
374 VAGINAL DISCHARGE 5 0.0005
375 GOITRE 2 0.0005
376 ABNORMAL FAECES 4 0.0005
377 ARTHRITIS BACTERIAL 2 0.0005
378 CAPILLARY LEAK SYNDROME 1 0.0005
379 THYROID FUNCTION TEST ABNORMAL 2 0.0005
380 BODY TEMPERATURE FLUCTUATION 1 0.0005
381 PRODUCT DOSE OMISSION ISSUE 139 0.0005
382 INJECTION SITE IRRITATION 6 0.0005
383 HEPATIC CYTOLYSIS 6 0.0005
384 POOR PERIPHERAL CIRCULATION 2 0.0005
385 PRODUCT DISPENSING ISSUE 2 0.0005
386 BLOOD TESTOSTERONE INCREASED 1 0.0005
387 POOR QUALITY DRUG ADMINISTERED 3 0.0005
388 VAGINAL HAEMORRHAGE 20 0.0005
389 CERVICAL DYSPLASIA 1 0.0005
390 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
391 CORNEAL OEDEMA 1 0.0004
392 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
393 LIP DRY 4 0.0004
394 HAEMOGLOBIN INCREASED 2 0.0004
395 PRODUCT PREPARATION ERROR 9 0.0004
396 NEPHROTIC SYNDROME 3 0.0004
397 HUNGER 6 0.0004
398 INJECTION SITE REACTION 29 0.0004
399 METASTASIS 3 0.0004
400 GESTATIONAL DIABETES 2 0.0004
401 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
402 CIRCULATORY COLLAPSE 7 0.0004
403 GLOMERULONEPHRITIS 1 0.0004
404 INJECTION SITE URTICARIA 10 0.0004
405 INJECTION SITE ABSCESS 1 0.0004
406 INFREQUENT BOWEL MOVEMENTS 1 0.0004
407 BREAST TENDERNESS 3 0.0004
408 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
409 APPENDICITIS PERFORATED 1 0.0004
410 HAEMORRHAGE URINARY TRACT 1 0.0004
411 INJURY ASSOCIATED WITH DEVICE 8 0.0004
412 INCREASED BRONCHIAL SECRETION 1 0.0004
413 HEPATOSPLENOMEGALY 1 0.0004
414 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
415 CONGENITAL ANOMALY 3 0.0004
416 COMPARTMENT SYNDROME 1 0.0004
417 ABDOMINAL PAIN 88 0.0004
418 PREMATURE DELIVERY 6 0.0004
419 ABDOMINAL MASS 1 0.0004
420 INJECTION SITE PRURITUS 25 0.0004
421 RHINITIS 3 0.0004
422 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
423 PRODUCT STORAGE ERROR 32 0.0004
424 AUTISM SPECTRUM DISORDER 2 0.0004
425 PRODUCT USE IN UNAPPROVED INDICATION 90 0.0004
426 ATRIAL SEPTAL DEFECT 3 0.0004
427 MACULAR OEDEMA 2 0.0004
428 VENTRICULAR SEPTAL DEFECT 2 0.0003
429 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
430 COMA SCALE ABNORMAL 1 0.0003
431 HAEMOTHORAX 1 0.0003
432 URINE OUTPUT DECREASED 3 0.0003
433 PRODUCT LABEL CONFUSION 2 0.0003
434 HYPOVOLAEMIA 2 0.0003
435 BRAIN HERNIATION 1 0.0003
436 DEVELOPMENTAL DELAY 3 0.0003
437 KERATITIS 1 0.0003
438 DYSCHEZIA 1 0.0003
439 INTRACARDIAC THROMBUS 1 0.0003
440 MUSCULOSKELETAL CHEST PAIN 5 0.0003
441 APPENDICITIS 3 0.0003
442 PRE-EXISTING CONDITION IMPROVED 2 0.0003
443 BLOOD CREATININE DECREASED 1 0.0003
444 CARDIOVASCULAR DISORDER 8 0.0003
445 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
446 PANCREATITIS ACUTE 7 0.0003
447 HEPATITIS ACUTE 2 0.0003
448 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
449 BREAST ENLARGEMENT 1 0.0003
450 INJECTION SITE INFECTION 1 0.0003
451 ADVERSE REACTION 4 0.0003
452 SPINAL FRACTURE 6 0.0003
453 INJECTION SITE MASS 11 0.0003
454 PRODUCT ADMINISTRATION ERROR 6 0.0003
455 METASTASES TO LYMPH NODES 2 0.0003
456 HEPATIC CYST 1 0.0003
457 INJECTION SITE RASH 9 0.0003
458 METRORRHAGIA 5 0.0003
459 DYSPNOEA EXERTIONAL 11 0.0003
460 PERITONITIS 6 0.0003
461 VENTRICULAR EXTRASYSTOLES 3 0.0003
462 HYPERTRANSAMINASAEMIA 2 0.0003
463 PETECHIAE 3 0.0003
464 INJECTION SITE DISCOMFORT 3 0.0003
465 HANGOVER 1 0.0003
466 COLD SWEAT 5 0.0003
467 THERMAL BURN 2 0.0003
468 EXPOSURE VIA SKIN CONTACT 7 0.0003
469 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
470 AUTOIMMUNE THYROIDITIS 1 0.0003
471 INJECTION SITE PAIN 81 0.0003
472 FACE INJURY 1 0.0003
473 EXPOSURE DURING PREGNANCY 16 0.0003
474 CARDIOPULMONARY FAILURE 1 0.0003
475 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
476 HAEMATOCRIT DECREASED 5 0.0003
477 PRODUCT PRESCRIBING ERROR 6 0.0003
478 RENAL CYST 2 0.0003
479 MOOD SWINGS 8 0.0003
480 HYPERPHAGIA 1 0.0003
481 CANDIDIASIS 1 0.0002
482 BLEPHARITIS 1 0.0002
483 CYSTITIS HAEMORRHAGIC 1 0.0002
484 ENURESIS 1 0.0002
485 FIBROMYALGIA 6 0.0002
486 BODY TEMPERATURE INCREASED 5 0.0002
487 INJECTION SITE WARMTH 5 0.0002
488 GENERALISED OEDEMA 3 0.0002
489 MENSTRUAL DISORDER 2 0.0002
490 HEMIPLEGIA 2 0.0002
491 DERMATITIS ALLERGIC 3 0.0002
492 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
493 INTESTINAL STENOSIS 1 0.0002
494 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
495 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
496 POOR QUALITY SLEEP 5 0.0002
497 CHAPPED LIPS 1 0.0002
498 HYPERKALAEMIA 8 0.0002
499 BLOOD CALCIUM INCREASED 2 0.0002
500 PRODUCT COMMUNICATION ISSUE 2 0.0002
501 LIGAMENT RUPTURE 1 0.0002
502 INJECTION SITE ERYTHEMA 28 0.0002
503 HOT FLUSH 17 0.0002
504 HAEMOLYTIC ANAEMIA 2 0.0002
505 LOSS OF LIBIDO 2 0.0002
506 INJECTION SITE PAPULE 1 0.0002
507 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
508 IMMUNE THROMBOCYTOPENIA 1 0.0002
509 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
510 DYSPAREUNIA 1 0.0002
511 INTERCEPTED MEDICATION ERROR 1 0.0002
512 ERYTHEMA MULTIFORME 2 0.0002
513 BLOOD SODIUM DECREASED 4 0.0002
514 BLOOD PROLACTIN INCREASED 1 0.0002
515 SYNCOPE 21 0.0002
516 ATELECTASIS 2 0.0002
517 GUILLAIN-BARRE SYNDROME 1 0.0002
518 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
519 CEREBRAL INFARCTION 5 0.0002
520 INCORRECT DOSAGE ADMINISTERED 1 0.0002
521 PHARYNGEAL SWELLING 2 0.0002
522 ABDOMINAL TENDERNESS 1 0.0002
523 INJECTION SITE BRUISING 16 0.0002
524 POOR QUALITY DEVICE USED 2 0.0002
525 OSTEOPENIA 3 0.0002
526 SLUGGISHNESS 2 0.0002
527 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
528 HYPONATRAEMIA 11 0.0002
529 EAR DISCOMFORT 2 0.0002
530 INCREASED UPPER AIRWAY SECRETION 1 0.0002
531 THYROID DISORDER 3 0.0002
532 EMOTIONAL DISORDER 6 0.0002
533 CACHEXIA 1 0.0002
534 DRUG DOSE OMISSION 32 0.0002
535 FAILURE TO THRIVE 1 0.0002
536 CATATONIA 1 0.0002
537 PRODUCT USE COMPLAINT 3 0.0002
538 RENAL PAIN 2 0.0002
539 BREAST PAIN 2 0.0002
540 INTESTINAL RESECTION 1 0.0002
541 DECREASED ACTIVITY 2 0.0002
542 BLOOD BILIRUBIN INCREASED 5 0.0002
543 ABDOMINAL DISCOMFORT 31 0.0002
544 MENSTRUATION DELAYED 2 0.0002
545 INCORRECT DOSE ADMINISTERED 42 0.0002
546 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
547 INJECTION SITE SWELLING 14 0.0002
548 MANIA 3 0.0002
549 GASTROINTESTINAL PAIN 2 0.0002
550 INJECTION SITE NODULE 2 0.0002
551 INTESTINAL ISCHAEMIA 1 0.0002
552 DEAFNESS UNILATERAL 1 0.0002
553 CYSTIC FIBROSIS 1 0.0002
554 INJECTION SITE INJURY 1 0.0002
555 INTRACRANIAL PRESSURE INCREASED 1 0.0002
556 INTERMENSTRUAL BLEEDING 1 0.0002
557 GENERALISED ERYTHEMA 1 0.0002
558 INTENTIONAL DOSE OMISSION 5 0.0002
559 CHOLECYSTECTOMY 2 0.0002
560 METASTASES TO LUNG 2 0.0002
561 HYPERVENTILATION 1 0.0002
562 ORTHOSTATIC HYPOTENSION 3 0.0002
563 POST PROCEDURAL HAEMORRHAGE 2 0.0002
564 ENERGY INCREASED 1 0.0002
565 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
566 PULMONARY EMBOLISM 16 0.0002
567 ISCHAEMIC STROKE 3 0.0002
568 THIRST 3 0.0002
569 CHOLECYSTITIS 2 0.0002
570 GASTROENTERITIS VIRAL 3 0.0002
571 LEUKOCYTOSIS 3 0.0002
572 INJECTION SITE VESICLES 1 0.0002
573 ADRENAL INSUFFICIENCY 2 0.0002
574 INGUINAL HERNIA 1 0.0002
575 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
576 PALPITATIONS 19 0.0002
577 CYST 2 0.0002
578 INJECTION SITE DISCOLOURATION 2 0.0002
579 BLEPHAROSPASM 1 0.0002
580 HYPOTHYROIDISM 5 0.0002
581 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
582 CHEST DISCOMFORT 16 0.0002
583 CHOLESTASIS 3 0.0002
584 PRESCRIBED OVERDOSE 3 0.0002
585 HYPERPROLACTINAEMIA 1 0.0002
586 HERPES SIMPLEX 1 0.0002
587 PLATELET COUNT INCREASED 2 0.0002
588 CHOLELITHIASIS 5 0.0002
589 ANKYLOSING SPONDYLITIS 2 0.0002
590 PANCREATITIS 8 0.0002
591 DYSMENORRHOEA 2 0.0002
592 INTENTIONAL PRODUCT MISUSE 13 0.0001
593 TACHYPNOEA 2 0.0001
594 PALLOR 4 0.0001
595 HEADACHE 92 0.0001
596 MOOD ALTERED 4 0.0001
597 JOINT EFFUSION 1 0.0001
598 DRUG INTERACTION 23 0.0001
599 RESPIRATORY DISTRESS 4 0.0001
600 ABNORMAL DREAMS 4 0.0001
601 HAIR GROWTH ABNORMAL 1 0.0001
602 PROCEDURAL PAIN 4 0.0001
603 EXTRASYSTOLES 1 0.0001
604 OSTEOARTHRITIS 6 0.0001
605 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
606 FEAR OF INJECTION 1 0.0001
607 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
608 PRURITUS GENERALISED 3 0.0001
609 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
610 FLUID OVERLOAD 2 0.0001
611 APATHY 2 0.0001
612 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
613 CEREBRAL DISORDER 1 0.0001
614 CONTUSION 13 0.0001
615 WEIGHT INCREASED 30 0.0001
616 HYDRONEPHROSIS 1 0.0001
617 IRRITABILITY 8 0.0001
618 DERMATITIS ATOPIC 7 0.0001
619 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
620 HYPERTHERMIA 1 0.0001
621 LIPASE INCREASED 1 0.0001
622 PHARYNGEAL OEDEMA 2 0.0001
623 DYSPNOEA 73 0.0001
624 HYPOALBUMINAEMIA 1 0.0001
625 APNOEA 1 0.0001
626 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
627 HAEMORRHAGIC STROKE 1 0.0001
628 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
629 NAUSEA 100 0.0001
630 BLOOD ALBUMIN DECREASED 1 0.0001
631 BLOOD DISORDER 1 0.0001
632 NIGHT SWEATS 4 0.0001
633 UNDERDOSE 9 0.0001
634 LIVER INJURY 3 0.0001
635 METASTASES TO BONE 2 0.0001
636 LETHARGY 7 0.0001
637 ESCHERICHIA INFECTION 1 0.0001
638 ACUTE CORONARY SYNDROME 1 0.0001
639 EMBOLISM 1 0.0001
640 EXPIRED PRODUCT ADMINISTERED 4 0.0001
641 BREAST CANCER STAGE II 1 0.0001
642 COAGULOPATHY 2 0.0001
643 URTICARIA 20 0.0001
644 HAEMODIALYSIS 1 0.0001
645 HEMIPARESIS 2 0.0001
646 FACIAL PARALYSIS 1 0.0001
647 PRODUCT USE ISSUE 22 0.0001
648 ERECTILE DYSFUNCTION 3 0.0001
649 HAEMATURIA 4 0.0001
650 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
651 DIPLOPIA 3 0.0001
652 DEVICE DEFECTIVE 2 0.0001
653 MUSCLE SPASMS 21 0.0001
654 DEVICE USE ISSUE 2 0.0001
655 AMENORRHOEA 2 0.0001
656 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
657 DEPRESSED MOOD 6 0.0001
658 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
659 HAEMARTHROSIS 1 0.0001
660 HIDRADENITIS 1 0.0001
661 OFF LABEL USE 96 0.0001
662 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
663 ADVERSE EVENT 10 0.0001
664 GRAND MAL CONVULSION 1 0.0001
665 FLANK PAIN 1 0.0001
666 LACERATION 1 0.0001
667 CONDITION AGGRAVATED 32 0.0001
668 POST PROCEDURAL COMPLICATION 2 0.0001
669 ORAL HERPES 2 0.0001
670 VOMITING 48 0.0001
671 COELIAC DISEASE 1 0.0001
672 MENORRHAGIA 2 0.0001
673 INJECTION SITE HAEMORRHAGE 8 0.0001
674 BURNING SENSATION 7 0.0001
675 SLEEP DISORDER 7 0.0001
676 DRY THROAT 1 0.0001
677 SUICIDAL IDEATION 9 0.0001
678 DRUG ADMINISTRATION ERROR 3 0.0001
679 MOBILITY DECREASED 7 0.0001
680 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
681 LIMB DISCOMFORT 3 0.0001
682 DIZZINESS 48 0.0001
683 HAEMORRHAGE 10 0.0001
684 DRUG INEFFECTIVE 125 0.0001
685 HALLUCINATION, VISUAL 2 0.0001
686 FULL BLOOD COUNT ABNORMAL 1 0.0001
687 RETCHING 2 0.0001
688 IMPAIRED WORK ABILITY 2 0.0001
689 HEREDITARY ANGIOEDEMA 1 0.0001
690 BREAST CANCER METASTATIC 1 0.0001
691 FATIGUE 72 0.0001
692 DEEP VEIN THROMBOSIS 6 0.0001
693 OEDEMA 5 0.0001
694 BACK INJURY 1 0.0001
695 PRODUCT DISPENSING ERROR 2 0.0001
696 FEELING ABNORMAL 22 0.0001
697 CONSTIPATION 20 0.0001
698 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
699 EYE DISORDER 3 0.0001
700 ASTHENIA 34 0.0001
701 TRANSAMINASES INCREASED 2 0.0001
702 URINARY RETENTION 3 0.0001
703 RASH MACULO-PAPULAR 2 0.0001
704 HYPERTENSIVE CRISIS 1 0.0001
705 COLITIS ULCERATIVE 4 0.0001
706 NECK PAIN 5 0.0001
707 MALNUTRITION 1 0.0001
708 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
709 FLATULENCE 5 0.0001
710 HEPATIC ENZYME INCREASED 6 0.0001
711 IMPAIRED DRIVING ABILITY 1 0.0001
712 MUSCLE TWITCHING 2 0.0001
713 PERICARDIAL EFFUSION 2 0.0001
714 HYPERSENSITIVITY 16 0.0001
715 ELECTROLYTE IMBALANCE 1 0.0001
716 EYELID OEDEMA 1 0.0001
717 COGNITIVE DISORDER 4 0.0001
718 SWELLING 8 0.0001
719 BLOOD IRON DECREASED 1 0.0001
720 MENTAL IMPAIRMENT 2 0.0001
721 THERAPEUTIC RESPONSE DECREASED 5 0.0001
722 C-REACTIVE PROTEIN INCREASED 3 0.0001
723 BURSITIS 1 0.0001
724 PRESYNCOPE 2 0.0001
725 RESTLESSNESS 3 0.0001
726 CYTOPENIA 1 0.0001
727 CARDIOMEGALY 1 0.0001
728 HEPATIC FUNCTION ABNORMAL 3 0.0001
729 BRAIN OEDEMA 1 0.0001
730 HYPOPHAGIA 2 0.0001
731 PERIPHERAL SWELLING 12 0.0001
732 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
733 HIATUS HERNIA 1 0.0001
734 RASH GENERALISED 2 0.0001
735 INJECTION SITE INDURATION 1 0.0001
736 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
737 IMMUNE SYSTEM DISORDER 1 0.0001
738 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
739 PAIN 46 0.0001
740 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
741 SOMNOLENCE 15 0.0001
742 LIMB INJURY 2 0.0001
743 POLLAKIURIA 3 0.0001
744 HYPOMAGNESAEMIA 1 0.0001
745 CARDIO-RESPIRATORY ARREST 3 0.0001
746 APHONIA 1 0.0001
747 BLOOD TEST ABNORMAL 1 0.0001
748 RASH 31 0.0001
749 RENAL FAILURE ACUTE 3 0.0001
750 HEART RATE INCREASED 7 0.0001
751 PAIN IN JAW 2 0.0001
752 HERPES ZOSTER 4 0.0001
753 INJECTION SITE HAEMATOMA 1 0.0001
754 HYPOKINESIA 1 0.0001
755 LABORATORY TEST ABNORMAL 2 0.0001
756 PSYCHOTIC DISORDER 2 0.0001
757 HAEMORRHAGE INTRACRANIAL 1 0.0001
758 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
759 THERAPY NON-RESPONDER 3 0.0001
760 APHASIA 2 0.0001
761 ECONOMIC PROBLEM 1 0.0001
762 VERTIGO 4 0.0001
763 DISCOMFORT 4 0.0001
764 SKIN IRRITATION 3 0.0001
765 DRUG DISPENSING ERROR 1 0.0001
766 PRURITUS 25 0.0001
767 HYPOKALAEMIA 3 0.0001
768 GYNAECOMASTIA 2 0.0001
769 ACUTE MYELOID LEUKAEMIA 1 0.0001
770 MENINGIOMA 1 0.0001
771 SWOLLEN TONGUE 2 0.0001
772 BRAIN FOG 1 0.0001
773 ANXIETY 18 0.0001
774 ABDOMINAL PAIN UPPER 13 0.0001
775 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
776 COMA 3 0.0001
777 HALLUCINATION, AUDITORY 1 0.0001
778 MIGRAINE 6 0.0001
779 RASH ERYTHEMATOUS 3 0.0001
780 BLOOD POTASSIUM INCREASED 1 0.0001
781 MALAISE 27 0.0001
782 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
783 WEIGHT DECREASED 17 0.0001
784 FUNGAL INFECTION 2 0.0001
785 DRY SKIN 8 0.0001
786 GAIT INABILITY 2 0.0001
787 FLUID RETENTION 3 0.0001
788 ECZEMA 3 0.0001
789 LOCAL SWELLING 1 0.0001
790 SPEECH DISORDER 3 0.0001
791 LYMPHADENOPATHY 2 0.0001
792 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
793 HEAD DISCOMFORT 1 0.0001
794 DRUG ERUPTION 1 0.0001
795 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
796 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
797 DRUG EFFECT DECREASED 3 0.0001
798 COMPLICATION OF DEVICE REMOVAL 1 0.0001
799 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
800 CRYING 2 0.0001
801 PANIC ATTACK 2 0.0001
802 END STAGE RENAL DISEASE 1 0.0001
803 ACCIDENTAL OVERDOSE 2 0.0001
804 HYPERHIDROSIS 7 0.0001
805 DYSURIA 2 0.0001
806 ANAPHYLACTIC REACTION 3 0.0001
807 BLOOD GLUCOSE ABNORMAL 1 0.0001
808 MEDICATION ERROR 3 0.0001
809 HEPATIC STEATOSIS 1 0.0001
810 ERYTHEMA 11 0.0001
811 UNEVALUABLE EVENT 4 0.0001
812 BLOOD URINE PRESENT 1 0.0001
813 FEELING JITTERY 1 0.0001
814 INCREASED APPETITE 1 0.0001
815 BLOOD PRESSURE INCREASED 8 0.0001
816 DRUG PRESCRIBING ERROR 1 0.0001
817 SEIZURE 6 0.0001
818 GLAUCOMA 1 0.0001
819 ERUCTATION 1 0.0001
820 DECREASED APPETITE 12 0.0001
821 BONE PAIN 3 0.0001
822 CHILLS 6 0.0001
823 SURGERY 3 0.0001
824 NASAL CONGESTION 3 0.0001
825 DYSPEPSIA 5 0.0001
826 DISORIENTATION 2 0.0001
827 THROMBOSIS 4 0.0000
828 DIARRHOEA 32 0.0000
829 SUICIDE ATTEMPT 3 0.0000
830 ILL-DEFINED DISORDER 3 0.0000
831 FEEDING DISORDER 1 0.0000
832 FLUSHING 5 0.0000
833 FEELING HOT 3 0.0000
834 LUNG NEOPLASM MALIGNANT 2 0.0000
835 OSTEOPOROSIS 2 0.0000
836 CHEST PAIN 9 0.0000
837 VISUAL IMPAIRMENT 6 0.0000
838 DEPRESSION 11 0.0000
839 TREATMENT FAILURE 4 0.0000
840 DERMATITIS 1 0.0000
841 RENAL IMPAIRMENT 4 0.0000
842 EATING DISORDER 1 0.0000
843 JOINT INJURY 1 0.0000
844 HYPOAESTHESIA 7 0.0000
845 LIVER FUNCTION TEST INCREASED 1 0.0000
846 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
847 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
848 APPLICATION SITE PAIN 1 0.0000
849 INFUSION RELATED REACTION 3 0.0000
850 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
851 TACHYCARDIA 4 0.0000
852 DEHYDRATION 6 0.0000
853 THROMBOCYTOPENIA 5 0.0000
854 HEART RATE IRREGULAR 1 0.0000
855 NEPHROLITHIASIS 2 0.0000
856 TINNITUS 2 0.0000
857 PYREXIA 15 0.0000
858 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
859 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
860 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
861 HYPERTENSION 9 0.0000
862 ARRHYTHMIA 2 0.0000
863 DISEASE RECURRENCE 2 0.0000
864 THERAPY INTERRUPTED 3 0.0000
865 EMOTIONAL DISTRESS 5 0.0000
866 HYPOGLYCAEMIA 2 0.0000
867 MYALGIA 7 0.0000
868 OEDEMA PERIPHERAL 5 0.0000
869 LUNG DISORDER 2 0.0000
870 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
871 LEUKOPENIA 2 0.0000
872 ACNE 3 0.0000
873 CHRONIC KIDNEY DISEASE 3 0.0000
874 HAEMATEMESIS 1 0.0000
875 DRUG RESISTANCE 1 0.0000
876 INFLAMMATION 2 0.0000
877 HAEMATOMA 1 0.0000
878 MUSCULOSKELETAL PAIN 2 0.0000
879 JOINT STIFFNESS 1 0.0000
880 ANHEDONIA 1 0.0000
881 GASTRITIS 1 0.0000
882 INSOMNIA 10 0.0000
883 MENSTRUATION IRREGULAR 1 0.0000
884 FEAR 1 0.0000
885 DISTURBANCE IN ATTENTION 2 0.0000
886 OVERDOSE 8 0.0000
887 FREQUENT BOWEL MOVEMENTS 1 0.0000
888 CARDIAC ARREST 3 0.0000
889 DIVERTICULITIS 1 0.0000
890 FEELING COLD 1 0.0000
891 COUGH 10 0.0000
892 ASTHMA 4 0.0000
893 MUSCULAR WEAKNESS 4 0.0000
894 HYPERSOMNIA 1 0.0000
895 BACK PAIN 8 0.0000
896 LIVER FUNCTION TEST ABNORMAL 1 0.0000
897 DYSSTASIA 1 0.0000
898 MUSCULOSKELETAL STIFFNESS 3 0.0000
899 COVID-19 6 0.0000
900 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
901 NASOPHARYNGITIS 6 0.0000
902 BREAST CANCER 3 0.0000
903 DRUG-INDUCED LIVER INJURY 1 0.0000
904 HEAD INJURY 1 0.0000
905 CYSTITIS 1 0.0000
906 LOSS OF CONSCIOUSNESS 4 0.0000
907 DEVICE EXPULSION 2 0.0000
908 ALOPECIA 6 0.0000
909 DEVICE DIFFICULT TO USE 2 0.0000
910 BLOOD PRESSURE DECREASED 2 0.0000
911 ANGER 1 0.0000
912 CEREBROVASCULAR ACCIDENT 5 0.0000
913 URINARY TRACT INFECTION 5 0.0000
914 HAEMOGLOBIN DECREASED 3 0.0000
915 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
916 ILLNESS 3 0.0000
917 ARTHRALGIA 12 0.0000
918 DELIRIUM 1 0.0000
919 DEVICE USE ERROR 1 0.0000
920 INJURY 2 0.0000
921 RESPIRATORY FAILURE 2 0.0000
922 AGITATION 2 0.0000
923 PAIN IN EXTREMITY 8 0.0000
924 DYSGEUSIA 2 0.0000
925 INFLUENZA 3 0.0000
926 DYSARTHRIA 1 0.0000
927 INTESTINAL OBSTRUCTION 1 0.0000
928 COLITIS 1 0.0000
929 ANAEMIA 5 0.0000
930 ACUTE KIDNEY INJURY 4 0.0000
931 GAIT DISTURBANCE 5 0.0000
932 JOINT SWELLING 3 0.0000
933 DEVICE BREAKAGE 1 0.0000
934 BLINDNESS 1 0.0000
935 TREMOR 4 0.0000
936 HYPOACUSIS 1 0.0000
937 DEVICE LEAKAGE 1 0.0000
938 DEVICE DISLOCATION 1 0.0000
939 MENTAL DISORDER 1 0.0000
940 ANGIOEDEMA 1 0.0000
941 GASTROINTESTINAL DISORDER 2 0.0000
942 VISION BLURRED 3 0.0000
943 PNEUMONIA 7 0.0000
944 BLOOD CHOLESTEROL INCREASED 1 0.0000
945 FALL 7 0.0000
946 INFECTION 3 0.0000
947 DRUG INTOLERANCE 2 0.0000
948 INTERSTITIAL LUNG DISEASE 1 0.0000
949 DRY EYE 1 0.0000
950 AGGRESSION 1 0.0000
951 CELLULITIS 1 0.0000
952 PARAESTHESIA 3 0.0000
953 BRADYCARDIA 1 0.0000
954 CONFUSIONAL STATE 3 0.0000
955 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
956 ARTHROPATHY 1 0.0000
957 SEPSIS 2 0.0000
958 BLISTER 1 0.0000
959 RHEUMATOID ARTHRITIS 2 0.0000
960 CONVULSION 1 0.0000
961 EYE IRRITATION 1 0.0000
962 DYSPHONIA 1 0.0000
963 CATARACT 1 0.0000
964 BLOOD GLUCOSE INCREASED 3 0.0000
965 AMNESIA 1 0.0000
966 BLOOD CREATININE INCREASED 1 0.0000
967 PSORIASIS 2 0.0000
968 RENAL FAILURE 2 0.0000
969 HYPOTENSION 3 0.0000
970 DEVICE MALFUNCTION 1 0.0000
971 BRONCHITIS 1 0.0000
972 DRUG DOSE OMISSION BY DEVICE 1 0.0000
973 CARDIAC FAILURE 1 0.0000
974 DRY MOUTH 1 0.0000
975 INFLUENZA LIKE ILLNESS 1 0.0000
976 DRUG ABUSE 1 0.0000
977 BALANCE DISORDER 1 0.0000
978 DEVICE ISSUE 1 0.0000
979 ADVERSE DRUG REACTION 1 0.0000
980 CARDIAC DISORDER 1 0.0000
981 ATRIAL FIBRILLATION 1 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
983 DISEASE PROGRESSION 1 0.0000
984 MEMORY IMPAIRMENT 1 0.0000
985 HOSPITALISATION 1 0.0000
986 DEATH 4 0.0000